Mightier than the sword: smart pens and smart phones help maintain target blood glucose levels 27 September 2021 Smart insulin pens are an exciting new area of diabetes technology and a new study of Medtronic’s InPen has demonstrated how the pens are helping users improve their glucose management. One study, recently published by the American Diabetes Association, tracked the data of over 1500 people over almost three years and found that using a smart insulin pen helped people keep their blood glucose levels within their target range for longer. In some cases by more than an hour a day. The study also noted declines in hypoglycaemia amongst participants. A smart insulin pen works with a smart phone app to collect data, alert users to missed dosages and help inform dosing decisions. The study in full can be found here. Key Points smart insulin pens can be a helpful way of maintaining target blood glucose levelsby connecting to your phone, smart insulin pens can help you make informed decisions about your insulin managementinsulin management technology is a fast-growing industry, with a growing number of options to suit different lifestyles.
News 27 May 2026 Tzield listing a game-changer for early-stage type 1 diabetes The first new therapy for type 1 diabetes in nearly a century, which works to delay the need for insulin therapy in type 1 diabetes, has been approved for use in Australia by the Therapeutic Goods Administration. Continue Reading
Media releases 9 May 2026 Research reveals genes may determine who benefits most from popular weight-loss and diabetes medicines New research supported by Diabetes Australia has confirmed that a person’s genes can influence how well widely used diabetes medicines... Continue Reading
News 1 May 2026 Update issued for YpsoPump Orbit Micro 2.0 infusion sets to improve comfort People using YpsoPump Orbit Micro 2.0 infusion sets are being advised of a product update designed to improve comfort and reduce the likelihood of skin irritation. Continue Reading